Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2010
10/28/2010US20100273723 Peptides of il-2
10/28/2010US20100273722 Modified miniature proteins
10/28/2010US20100273721 Compositions and methods for treating ophthalmic disorders
10/28/2010US20100273720 Protective Complement Proteins and Age-Related Macular Degeneration
10/28/2010US20100273719 Use of somatostatin analogs in meningioma
10/28/2010US20100273718 Milk Protein Hydrolyzates with Reduced Immunogenic Potential
10/28/2010US20100273717 Use of an Extract from the Vigna Aconitifolia Plant in a Cosmetic and/or Dermopharmaceutical Composition
10/28/2010US20100273716 New uses for amino acid anticonvulsants
10/28/2010US20100273715 Use of a peptide and an analgesic pharmaceutical agent
10/28/2010US20100273714 Peptide compounds for treating refractory status epilepticus
10/28/2010US20100273713 Diagnosis and Treatment of Congenital Heart Defects Using NELL1
10/28/2010US20100273712 Surfactant usage in lung transplantation and methods thereof
10/28/2010US20100273711 Individualized cancer treatments
10/28/2010US20100273710 Highly Potent Full and Partial Agonists and Antagonists of the Nociceptin/Orphanin FQ Receptor
10/28/2010US20100273709 Composition Comprising Desmopressin
10/28/2010US20100273708 Adiponectin expression-inducing agents and uses thereof
10/28/2010US20100273707 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
10/28/2010US20100273706 Injectable Calcium Phosphate Solid Rods and Pastes for Delivery of Osteogenic Proteins
10/28/2010US20100273705 Method for inhibiting "Melanoma Inhibitory Activity" MIA
10/28/2010US20100273704 Methods of modulating cellular homeostatic pathways and cellular survival
10/28/2010US20100273703 Co-Therapy For Diabetic Conditions
10/28/2010US20100273702 Chimerical peptidic molecules with antiviral properties against the viruses of the flaviviridae family
10/28/2010US20100273701 Use of salusin beta alone or in combination with octreotide as a therapeutic agent
10/28/2010US20100273700 Use of a peptide as a therapeutic agent
10/28/2010US20100273274 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
10/28/2010US20100273265 for inducing differentiation into retinal photoreceptor cells; for preventing/treating/suppressing progression of retinal diseases; retinitis pigmentosa, senile macular degeneration, diabetic retinopathy, retinal detachment, glaucoma and retinal vessel occlusion
10/28/2010US20100273174 Antibodies to tumor associated proteins
10/28/2010US20100273158 HIN-1, A Tumor Suppressor Gene
10/28/2010US20100272823 Pulmonary delivery particles comprising water insoluble or crystalline active agents
10/28/2010US20100272822 Nanocell drug delivery system
10/28/2010US20100272820 Preparation Method of Sustained-Release Microcapsules Having Good Initial Burst Inhibiting Property and the Microcapsules Thereby
10/28/2010US20100272817 Compositions and Methods for Treating Atherosclerosis
10/28/2010US20100272810 Delivery System for Binding and Release of Growth Factors
10/28/2010US20100272809 Microparticles comprising somatostatin analogues
10/28/2010US20100272808 Shell-and-Core Dosage Form Approaching Zero-Order Drug Release
10/28/2010US20100272805 Hydrogels for combinatorial delivery of immune-modulating biomolecules
10/28/2010US20100272797 Pharmaceutical Composition for Treating Hepatitis C Virus Infection Comprising HMG-COA Reductase Inhibitor and Bile Acid
10/28/2010US20100272790 Methods of Treating Skin
10/28/2010US20100272787 Amethod of treating neurodegenerative diseases
10/28/2010US20100272777 Ocular therapeutic agent delivery devices and methdos for making and using such devices
10/28/2010US20100272775 Immobilized biologically active entities having a high degree of biological activity following sterilization
10/28/2010US20100272761 Synthesis of lipoamide-grafted high molecular compound and method therefor
10/28/2010US20100272754 Botulinum toxin administration to treat various conditions
10/28/2010US20100272742 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
10/28/2010US20100272739 Modulation of Gamma-Delta T Cells to Regulate Airway Hyperresponsiveness
10/28/2010US20100272737 Novel Peptides and Protein and Uses Thereof
10/28/2010US20100272733 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf)
10/28/2010US20100272729 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272728 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272727 Compound for controlling appetite
10/28/2010US20100272726 Assays, methods and means
10/28/2010US20100272719 Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains
10/28/2010US20100272713 Genetic Markers Associated with Endometriosis and Use Thereof
10/28/2010US20100272712 Jnk3 as a target for the treatment of angiogenesis-related diseases
10/28/2010US20100272711 Compositions and methods for the treatment and prevention of cardiovascular diseases
10/28/2010US20100272710 Compositions and methods for treating and preventing aging-associated diseases
10/28/2010US20100272709 Cathepsin l mediated diseases and associated methods and products
10/28/2010US20100272708 Method for the treatment of type and type iv hypersensitivity
10/28/2010US20100272704 Novel patient subgroups for thrombolysis
10/28/2010US20100272703 Iron fortification mutritional blend
10/28/2010US20100272702 Methods and compositions for treating neuropathies
10/28/2010US20100272688 Method of treating or retarding the development of blindness
10/28/2010US20100272684 Hyperbaric treatment in wound healing
10/28/2010US20100272683 Heterocyclylaminoalkyl substituted benzimidazoles
10/28/2010US20100272682 Method for improving pharmacokinetics
10/28/2010US20100272681 Inhibitors of Serine Proteases
10/28/2010US20100272680 Piperidinyl Cyclic Amido Antiviral Agents
10/28/2010US20100272679 Compositions and methods of promoting wound healing
10/28/2010US20100272678 Anti-cancer drugs, and uses relating for malignant melanoma and other cancers
10/28/2010US20100272677 Heterocyclic antiviral compounds
10/28/2010US20100272676 Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
10/28/2010US20100272675 Method of administering conjugates
10/28/2010US20100272674 Hepatitis C Virus Inhibitors
10/28/2010US20100272659 Recombinant preparation of selected bromelain fractions
10/28/2010US20100272646 Method for inducing lymphoid tissue and modulating intestinal homeostasis
10/28/2010US20100272644 Complexation of fatty acid-conjugated molecules with albumin
10/28/2010US20100272643 Procaspase 8-Mediated Disease Targeting
10/28/2010US20100272636 Anti-CD74 Immunoconjugates and Methods of Use
10/28/2010US20100270228 Methods, Compositions And Devices For Maintaining Chemical Balance Of Chlorinated Water
10/28/2010US20100270197 Multipurpose packages for sterile products or products to be sterilised
10/28/2010US20100270183 Stable digestive enzyme compositions
10/28/2010DE4124468B4 Verfahren zur Gewinnung eines Polylactids in gereinigtem Zustand sowie ein Verfahren zur Herstellung einer pharmazeutischen Zusammensetzung mit den gereinigten Polylactiden A process for obtaining a polylactide in a purified state and a process for preparing a pharmaceutical composition comprising the purified polylactides
10/28/2010CA2759611A1 Compositions and methods for the treatment of chronic obstructive pulmonary disease and asthma
10/28/2010CA2759490A1 Tissue kallikrein for the treatment of huntington's disease
10/28/2010CA2759481A1 Tissue kallikrein for the treatment of schizophrenia and bipolar disorder
10/28/2010CA2759325A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
10/28/2010CA2759109A1 Method for the production of commercial nanoparticle and microparticle powders
10/28/2010CA2758976A1 Chemosensory receptor ligand-based therapies
10/28/2010CA2758571A1 Compositions containing hc-ha complex and methods of use thereof
10/28/2010CA2758532A1 Method and composition for synchronizing time of insemination
10/28/2010CA2757764A1 Cancer antigen helper peptide
10/28/2010CA2756074A1 Fast-acting insulin formulation
10/28/2010CA2744947A1 Use of epidermal growth factor inhibitors in the treatment of viral infection
10/27/2010EP2243837A1 Carotene synthase gene and uses therefor
10/27/2010EP2243828A1 Use of mixed lineage like kinase polypeptides (MLKL polypeptides) in cancer therapy
10/27/2010EP2243789A1 P.gingivalis antigenic composition
10/27/2010EP2243788A1 HIVCON: An HIV immunogen and uses thereof
10/27/2010EP2243787A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same
10/27/2010EP2243786A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
10/27/2010EP2243493A1 Immunopotentiative composition
1 ... 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 ... 3163